ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 215,22
0,52%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Exagen Inc (XGN)

  7. Exagen Inc (XGN) Actualités

XGN Exagen Inc

1,40
0,015 (1,08%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Exagen Inc XGN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,015 1,08% 1,40 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,38 1,3606 1,42 1,40 1,385
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202422:05GLOBEExagen to Announce First Quarter 2024 Results on May 13,..
26/4/202414:30GLOBEExagen Inc. Announces Changes to the Board of Directors
18/3/202413:00GLOBEExagen Inc. Reports Strong Fourth Quarter and Full-Year 2023..
18/3/202412:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
08/3/202415:00GLOBEExagen Inc. to Participate in the KeyBanc Capital..
07/3/202422:05GLOBEExagen to Announce Fourth Quarter 2023 and Full-Year..
06/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202413:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202421:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202422:05GLOBEExagen Inc. to Participate in the 2024 BTIG MedTech, Digital..
22/1/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202414:00EDGAR2Form 8-K - Current report
07/1/202418:00GLOBEExagen Inc. Announces Select Preliminary Full-Year 2023..
11/12/202322:05EDGAR2Form 8-K - Current report
30/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
29/11/202323:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/11/202322:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
20/11/202314:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/11/202322:30EDGAR2Form 8-K - Current report
17/11/202322:06EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202323:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:05EDGAR2Form 8-K - Current report
13/11/202322:05GLOBEExagen Inc. Reports Strong Third Quarter 2023 Results
09/11/202322:05GLOBEExagen Inc. and Johns Hopkins University Announce License..
02/11/202321:05GLOBEExagen Inc. to Participate in the 2023 Canaccord Genuity..
30/10/202321:05GLOBEExagen to Announce Third Quarter 2023 Financial Results on..
18/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202320:50DJNExagen Agrees to Pay Over $650K to Resolve Kickback..
28/9/202322:05GLOBEExagen Announces Acceptance of Multiple Abstracts at ACR..
12/9/202322:05GLOBEExagen Inc. to Participate in the 2023 Cantor Fitzgerald..
06/9/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202315:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202314:00EDGAR2Form 8-K - Current report
07/8/202314:00GLOBEExagen Inc. Reports Strong Second Quarter 2023 Results
26/7/202322:05GLOBEExagen Inc. to Participate in the Canaccord Genuity 43rd..
25/7/202322:05GLOBEExagen to Announce Second Quarter 2023 Financial Results on..
24/7/202322:05EDGAR2Form 8-K - Current report
24/7/202322:05GLOBEExagen Inc. Appoints Paul Kim to Board of Directors
30/5/202315:00GLOBEExagen Inc. to Participate in the William Blair 43rd Annual..
15/5/202322:05GLOBEExagen Inc. Reports First Quarter 2023 Results

Dernières Valeurs Consultées

NASDAQ
XGN
Exagen
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés